News
Day One Biopharmaceuticals' Q1'25 sales grew modestly, but Q2 2025 earnings could spark movement. Read why I currently rate ...
Tesla’s first-quarter 2025 results were disappointing as the company reported a 9% decline in total revenue year-over-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback